Form 4: Marcus Corp Director Acquires Restricted Stock

Sentiment:

Insider Transaction Report 5 January 2026 7:00 PM

Marcus Corp Director Bruce J. Olson acquired 4,174 shares of restricted common stock, which are held indirectly through a trust and vest over four years.

Summary

Director Bruce J. Olson acquired 4,174 shares of Marcus Corp (MCS) common stock on December 31, 2025, granted at a price of $0.
These shares are restricted stock, vesting 50% after the 2nd anniversary and 100% after the 4th anniversary of the grant date.
Following this acquisition, Olson's indirect beneficial ownership as trustee of the Bruce J. Olson & Barbara A. Olson Revocable Trust is 10,994 shares, which includes the newly acquired restricted stock.
Olson also directly owns 21,409 shares of common stock.
Additionally, Olson indirectly owns 1,350 shares as trustee of the Bruce Olson Family Trust.
Olson holds 7,643 stock options (right to buy) with exercise prices ranging from $14.25 to $38.51 and expiration dates between December 2026 and December 2033.

Sentiment

Score: 7

Explanation: The acquisition of restricted stock by a director, even at a $0 price, is generally viewed positively as it aligns the director's interests with long-term shareholder value through vesting conditions. It represents a form of compensation and commitment.

Positives

The acquisition of 4,174 restricted shares at a $0 price represents a form of compensation that aligns the director's long-term interests with shareholder value through its vesting schedule.
The continued holding of a significant number of common shares and stock options by a director indicates ongoing commitment to the company's performance.

Future Outlook

Industry Context

Related Party Transactions

Indirect ownership of 10,994 common shares through the Bruce J. Olson & Barbara A. Olson Revocable Trust, which includes the 4,174 newly acquired restricted shares.
Indirect ownership of 1,350 common shares through the Bruce Olson Family Trust.

Stakeholder Impact

Shareholders: The grant of restricted stock to a director can be seen as a positive signal, indicating management's long-term commitment and alignment with shareholder interests through performance-based compensation.

Next Steps

50% of the 4,174 restricted shares will vest after December 31, 2027 (2nd anniversary of grant).
100% of the 4,174 restricted shares will vest after December 31, 2029 (4th anniversary of grant).

Key Dates

Date	Description
12/29/2016	Date exercisable for 1,000 stock options with an exercise price of $31.55.
12/28/2017	Date exercisable for 1,000 stock options with an exercise price of $27.20.
12/27/2018	Date exercisable for 1,000 stock options with an exercise price of $38.51.
12/26/2019	Date exercisable for 1,000 stock options with an exercise price of $32.60.
12/30/2021	Date exercisable for 750 stock options with an exercise price of $17.95.
12/29/2022	Date exercisable for 1,438 stock options with an exercise price of $14.25.
12/28/2023	Date exercisable for 1,455 stock options with an exercise price of $14.69.
12/31/2025	Date of restricted stock grant (4,174 shares) and earliest transaction date reported.
01/05/2026	Signature date of the reporting person's attorney-in-fact.
12/29/2026	Expiration date for 1,000 stock options with an exercise price of $31.55.
12/28/2027	Expiration date for 1,000 stock options with an exercise price of $27.20.
12/28/2027	First vesting date for 50% of the 4,174 restricted shares (2nd anniversary of grant).
12/27/2028	Expiration date for 1,000 stock options with an exercise price of $38.51.
12/26/2029	Expiration date for 1,000 stock options with an exercise price of $32.60.
12/31/2029	Second vesting date for 100% of the 4,174 restricted shares (4th anniversary of grant).
12/30/2031	Expiration date for 750 stock options with an exercise price of $17.95.
12/29/2032	Expiration date for 1,438 stock options with an exercise price of $14.25.
12/28/2033	Expiration date for 1,455 stock options with an exercise price of $14.69.

Recommendation

hold

This Form 4 reports a routine grant of restricted stock to a director as part of their compensation package, which is a common practice to align management interests with shareholders. While it indicates continued commitment from the director, it does not present new information that would fundamentally alter the investment thesis for The Marcus Corporation, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Marcus Corp, MCS, Form 4, insider transaction, director compensation, restricted stock, stock options, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.